Stocks · News reference
China SXT Pharmaceuticals, Inc. announced it will implement a 1-for-100 reverse stock split of its Class A ordinary shares, effective October 26, 2026.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
China SXT Pharmaceuticals, Inc. has terminated the right of purchasers to acquire up to an additional $12 million in shares or pre-funded warrants from its October 8, 2026, registered direct offering.
U.S. stocks mixed: Dow rose 0.43%, while Nasdaq and S&P 500 fell. GE raised its forecast; oil gained and gold declined.